UTMD – Utah Medical Products, Inc.

Float Short %

3.24

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

62.27

Target Price

65.23

Analyst Recom

Performance Q

2.73

Relative Volume

0.66

Beta

0.34

Ticker: UTMD

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	UTMD	56.76	N/A	N/A	0
2025-12-29	UTMD	57.26	N/A	N/A	0
2025-12-30	UTMD	56.29	N/A	N/A	0
2025-12-31	UTMD	55.96	N/A	N/A	0
2026-01-02	UTMD	57	N/A	N/A	0
2026-01-05	UTMD	57.84	N/A	N/A	0
2026-01-06	UTMD	57.53	N/A	N/A	0
2026-01-07	UTMD	57.39	N/A	N/A	0
2026-01-08	UTMD	58.83	N/A	N/A	0
2026-01-09	UTMD	60.08	N/A	N/A	0
2026-01-12	UTMD	59.98	N/A	N/A	0
2026-01-13	UTMD	58.57	N/A	N/A	0
2026-01-14	UTMD	58.91	N/A	N/A	0
2026-01-15	UTMD	60.65	N/A	N/A	0
2026-01-16	UTMD	61.56	N/A	N/A	0
2026-01-20	UTMD	61.51	N/A	N/A	0
2026-01-21	UTMD	62.53	N/A	N/A	0
2026-01-22	UTMD	61.56	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	UTMD	56.80	-	-	-
2025-12-29	UTMD	57.13	-	-	-
2025-12-30	UTMD	56.44	-	-	-
2025-12-31	UTMD	56.15	-	-	-
2026-01-02	UTMD	56.40	-	-	-
2026-01-05	UTMD	57.51	-	-	-
2026-01-06	UTMD	57.24	-	-	-
2026-01-07	UTMD	57.38	-	-	-
2026-01-08	UTMD	58.75	-	-	-
2026-01-09	UTMD	60.03	-	-	-
2026-01-12	UTMD	59.68	-	-	-
2026-01-13	UTMD	58.55	-	-	-
2026-01-14	UTMD	58.82	-	-	-
2026-01-15	UTMD	60.21	-	-	-
2026-01-16	UTMD	61.25	-	-	-
2026-01-20	UTMD	61.50	-	-	-
2026-01-21	UTMD	62.70	-	-	-
2026-01-22	UTMD	62.27	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	UTMD	0.00	1.45	3.32
2025-12-29	UTMD	0.00	1.45	3.32
2025-12-30	UTMD	0.00	1.45	3.32
2025-12-31	UTMD	0.00	1.45	3.32
2026-01-02	UTMD	0.00	1.45	3.32
2026-01-05	UTMD	0.00	1.37	3.32
2026-01-06	UTMD	0.00	1.37	3.32
2026-01-07	UTMD	0.00	1.37	3.32
2026-01-08	UTMD	0.00	1.37	3.32
2026-01-09	UTMD	0.00	1.37	3.32
2026-01-12	UTMD	0.00	1.36	3.32
2026-01-13	UTMD	0.00	1.36	3.25
2026-01-14	UTMD	0.00	1.36	3.25
2026-01-15	UTMD	0.00	1.36	3.25
2026-01-16	UTMD	0.00	1.36	3.25
2026-01-20	UTMD	0.00	1.31	3.24
2026-01-21	UTMD	0.00	1.31	3.24
2026-01-22	UTMD	0.00	1.31	3.24
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.31

Beta

0.34

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

67.95

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.5

Max Drawdown 5-Year %

-55.6

Target Price

65.23

P/E

17.57

Forward P/E

PEG

P/S

5.15

P/B

1.68

P/Free Cash Flow

14.33

EPS

3.53

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

30.08

Relative Volume

0.66

Return on Equity vs Sector %

-17.4

Return on Equity vs Industry %

-0.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Utah Medical Products, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 155

Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

stock quote shares UTMD – Utah Medical Products, Inc. Stock Price stock today

news today UTMD – Utah Medical Products, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch UTMD – Utah Medical Products, Inc. yahoo finance google finance

stock history UTMD – Utah Medical Products, Inc. invest stock market

stock prices UTMD premarket after hours

ticker UTMD fair value insiders trading

ATRI – Atrion Corp.

Float Short %

2.53

Margin Of Safety %

-2

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

459.92

Target Price

300

Analyst Recom

Performance Q

-2.64

Relative Volume

Beta

0.69

Ticker: ATRI

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ATRI	459.92	N/A	N/A	0
2025-12-29	ATRI	459.92	N/A	N/A	0
2025-12-30	ATRI	459.92	N/A	N/A	0
2025-12-31	ATRI	459.92	N/A	N/A	0
2026-01-02	ATRI	459.92	N/A	N/A	0
2026-01-05	ATRI	459.92	N/A	N/A	0
2026-01-06	ATRI	459.92	N/A	N/A	0
2026-01-07	ATRI	459.92	N/A	N/A	0
2026-01-08	ATRI	459.92	N/A	N/A	0
2026-01-09	ATRI	459.92	N/A	N/A	0
2026-01-12	ATRI	459.92	N/A	N/A	0
2026-01-13	ATRI	459.92	N/A	N/A	0
2026-01-14	ATRI	459.92	N/A	N/A	0
2026-01-15	ATRI	459.92	N/A	N/A	0
2026-01-16	ATRI	459.92	N/A	N/A	0
2026-01-20	ATRI	459.92	N/A	N/A	0
2026-01-21	ATRI	459.92	N/A	N/A	0
2026-01-22	ATRI	459.92	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.69

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

452.44

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.7

Max Drawdown 5-Year %

-66

Target Price

300

P/E

64.5

Forward P/E

PEG

P/S

4.46

P/B

3.39

P/Free Cash Flow

29.24

EPS

7.13

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.91

Relative Volume

Return on Equity vs Sector %

-18.1

Return on Equity vs Industry %

-3.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

stock quote shares ATRI – Atrion Corp. Stock Price stock today

news today ATRI – Atrion Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATRI – Atrion Corp. yahoo finance google finance

stock history ATRI – Atrion Corp. invest stock market

stock prices ATRI premarket after hours

ticker ATRI fair value insiders trading

ATR – Aptargroup Inc.

Float Short %

1.92

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

-0.45

EPS Last/This Y

0.07

EPS This/Next Y

-0.12

Price

124.46

Target Price

158.33

Analyst Recom

1.9

Performance Q

-4.67

Relative Volume

0.62

Beta

0.48

Ticker: ATR

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ATR	123.32	1.02	0.00	2220
2025-12-29	ATR	123.21	1.02	8.00	2221
2025-12-30	ATR	122.72	1.02	999.99	2219
2025-12-31	ATR	121.99	1.02	0.00	2220
2026-01-02	ATR	122.5	1.02	0.90	2219
2026-01-05	ATR	122.95	1.02	0.00	2272
2026-01-06	ATR	120.56	1.02	0.00	2272
2026-01-07	ATR	120.49	1.02	999.99	2273
2026-01-08	ATR	122.43	1.03	0.00	2284
2026-01-09	ATR	123.77	1.02	0.86	2287
2026-01-12	ATR	125.12	0.99	0.93	1935
2026-01-13	ATR	123.51	0.98	0.99	1658
2026-01-14	ATR	126.88	0.97	0.98	1409
2026-01-15	ATR	124.98	0.95	0.96	1350
2026-01-16	ATR	124.59	0.93	0.17	1282
2026-01-20	ATR	123.79	0.77	0.14	339
2026-01-21	ATR	124.96	0.77	0.05	341
2026-01-22	ATR	124.47	0.71	0.33	359
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ATR	123.25	-18.7	-63.3	5.71
2025-12-29	ATR	123.18	-18.7	-65.4	5.71
2025-12-30	ATR	122.70	-18.7	-67.0	5.71
2025-12-31	ATR	121.97	-18.7	-67.9	5.71
2026-01-02	ATR	122.59	-18.7	-62.8	5.71
2026-01-05	ATR	122.98	-18.7	-63.5	5.71
2026-01-06	ATR	120.54	-18.7	-74.0	5.71
2026-01-07	ATR	120.42	-18.7	-65.6	5.71
2026-01-08	ATR	122.46	-18.7	-57.7	5.71
2026-01-09	ATR	123.86	-18.7	-60.0	5.71
2026-01-12	ATR	125.14	-18.7	-60.5	5.71
2026-01-13	ATR	123.51	-18.8	-70.9	5.71
2026-01-14	ATR	126.85	-18.8	-53.1	5.71
2026-01-15	ATR	125.10	-18.8	-71.3	5.71
2026-01-16	ATR	124.71	-19.2	-66.5	5.71
2026-01-20	ATR	123.79	-19.2	-68.4	5.71
2026-01-21	ATR	125.00	-19.2	-60.9	5.71
2026-01-22	ATR	124.46	-19.2	-67.0	5.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ATR	-2.79	-1.13	1.87
2025-12-29	ATR	-2.79	-1.13	1.87
2025-12-30	ATR	-2.79	-1.13	1.87
2025-12-31	ATR	-2.79	-1.13	1.87
2026-01-02	ATR	-2.79	-1.13	1.87
2026-01-05	ATR	-2.79	-1.14	1.87
2026-01-06	ATR	-2.79	-1.14	1.87
2026-01-07	ATR	-2.79	-1.14	1.87
2026-01-08	ATR	-2.79	-1.14	1.87
2026-01-09	ATR	-2.79	-1.14	1.87
2026-01-12	ATR	-2.82	-1.08	1.87
2026-01-13	ATR	-2.79	-1.08	1.87
2026-01-14	ATR	-2.79	-1.08	1.87
2026-01-15	ATR	-2.79	-1.08	1.87
2026-01-16	ATR	-2.79	-1.08	1.87
2026-01-20	ATR	-2.79	-0.25	1.87
2026-01-21	ATR	-2.79	-0.25	1.87
2026-01-22	ATR	-2.79	-0.25	1.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.62

Avg. EPS Est. Current Quarter

1.24

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

-2.79

Institutional Transactions

-0.25

Beta

0.48

Average Sales Estimate Current Quarter

880

Average Sales Estimate Next Quarter

929

Fair Value

132.46

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

30.1

Max Drawdown 5-Year %

-39.8

Target Price

158.33

P/E

19.95

Forward P/E

22.06

PEG

3.88

P/S

2.23

P/B

2.95

P/Free Cash Flow

25.94

EPS

6.24

Average EPS Est. Cur. Y

5.71

EPS Next Y. (Est.)

5.6

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.45

Relative Volume

0.62

Return on Equity vs Sector %

-12.1

Return on Equity vs Industry %

4.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-67

AptarGroup, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 13500

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

stock quote shares ATR – Aptargroup Inc. Stock Price stock today

news today ATR – Aptargroup Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATR – Aptargroup Inc. yahoo finance google finance

stock history ATR – Aptargroup Inc. invest stock market

stock prices ATR premarket after hours

ticker ATR fair value insiders trading

ANIK – Anika Therapeutics Inc.

Float Short %

4.21

Margin Of Safety %

-24

Put/Call OI Ratio

0.13

EPS Next Q Diff

0.17

EPS Last/This Y

-0.29

EPS This/Next Y

0.39

Price

9.39

Target Price

Analyst Recom

Performance Q

-3.99

Relative Volume

0.61

Beta

0.43

Ticker: ANIK

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ANIK	9.56	0.12	0.00	511
2025-12-29	ANIK	9.51	0.12	999.99	523
2025-12-30	ANIK	9.55	0.13	999.99	528
2025-12-31	ANIK	9.61	0.13	999.99	528
2026-01-02	ANIK	9.35	0.13	999.99	528
2026-01-05	ANIK	9.47	0.13	999.99	529
2026-01-06	ANIK	9.66	0.13	999.99	529
2026-01-07	ANIK	9.84	0.13	999.99	529
2026-01-08	ANIK	9.57	0.15	0.00	539
2026-01-09	ANIK	9.51	0.15	0.00	539
2026-01-12	ANIK	9.42	0.15	0.00	549
2026-01-13	ANIK	9.52	0.15	0.00	549
2026-01-14	ANIK	9.53	0.14	0.00	579
2026-01-15	ANIK	9.51	0.14	0.04	579
2026-01-16	ANIK	9.31	0.13	0.00	605
2026-01-20	ANIK	9.46	0.13	0.00	605
2026-01-21	ANIK	9.51	0.13	0.00	605
2026-01-22	ANIK	9.38	0.13	0.00	605
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ANIK	9.56	166.7	-	-0.13
2025-12-29	ANIK	9.52	166.7	-	-0.13
2025-12-30	ANIK	9.54	166.7	-	-0.13
2025-12-31	ANIK	9.62	166.7	-	-0.13
2026-01-02	ANIK	9.35	166.7	-	-0.13
2026-01-05	ANIK	9.46	166.7	-	-0.13
2026-01-06	ANIK	9.66	166.7	-	-0.13
2026-01-07	ANIK	9.85	166.7	-	-0.13
2026-01-08	ANIK	9.56	166.7	-	-0.13
2026-01-09	ANIK	9.49	166.7	-	-0.13
2026-01-12	ANIK	9.41	166.7	-	-0.13
2026-01-13	ANIK	9.52	166.7	-	-0.13
2026-01-14	ANIK	9.52	166.7	-	-0.13
2026-01-15	ANIK	9.52	166.7	-	-0.13
2026-01-16	ANIK	9.31	166.7	-	-0.13
2026-01-20	ANIK	9.48	166.7	-	-0.13
2026-01-21	ANIK	9.52	166.7	-	-0.13
2026-01-22	ANIK	9.39	166.7	-	-0.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ANIK	0.00	-0.70	3.63
2025-12-29	ANIK	0.00	-0.70	3.63
2025-12-30	ANIK	0.00	-0.70	3.63
2025-12-31	ANIK	0.00	-0.70	3.63
2026-01-02	ANIK	0.00	-0.70	3.63
2026-01-05	ANIK	0.00	-0.85	3.63
2026-01-06	ANIK	0.00	-0.85	3.63
2026-01-07	ANIK	0.00	-0.85	3.63
2026-01-08	ANIK	0.00	-0.85	3.63
2026-01-09	ANIK	0.00	-0.85	3.63
2026-01-12	ANIK	0.00	-0.85	3.63
2026-01-13	ANIK	0.00	-0.85	4.21
2026-01-14	ANIK	0.00	-0.85	4.21
2026-01-15	ANIK	0.00	-0.85	4.21
2026-01-16	ANIK	0.00	-0.85	4.21
2026-01-20	ANIK	0.00	-10.76	4.21
2026-01-21	ANIK	0.00	-10.76	4.21
2026-01-22	ANIK	0.00	-10.76	4.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-10.76

Beta

0.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

7.1

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

80.6

Max Drawdown 5-Year %

-83.2

Target Price

P/E

Forward P/E

PEG

P/S

1.2

P/B

0.92

P/Free Cash Flow

208.32

EPS

-2.28

Average EPS Est. Cur. Y

-0.13

EPS Next Y. (Est.)

0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-29.29

Relative Volume

0.61

Return on Equity vs Sector %

-49.8

Return on Equity vs Industry %

-29.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 288

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANGO – Angiodynamic Inc

Float Short %

5.33

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

EPS Last/This Y

0.54

EPS This/Next Y

0.18

Price

10.61

Target Price

19.33

Analyst Recom

Performance Q

-9.15

Relative Volume

0.77

Beta

0.53

Ticker: ANGO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ANGO	13.1	0.22	4.20	2219
2025-12-29	ANGO	12.86	0.22	1.00	2227
2025-12-30	ANGO	13.01	0.23	1.25	2251
2025-12-31	ANGO	12.83	0.23	0.42	2281
2026-01-02	ANGO	12.67	0.24	0.16	2309
2026-01-05	ANGO	13.21	0.24	0.54	2419
2026-01-06	ANGO	11.44	0.32	0.16	3624
2026-01-07	ANGO	10.91	0.17	0.82	5527
2026-01-08	ANGO	10.06	0.17	0.27	5595
2026-01-09	ANGO	9.85	0.16	0.40	6064
2026-01-12	ANGO	10.22	0.16	0.16	6170
2026-01-13	ANGO	10.08	0.16	0.03	6158
2026-01-14	ANGO	10.24	0.16	0.03	6166
2026-01-15	ANGO	11.01	0.16	0.16	6342
2026-01-16	ANGO	10.44	0.15	0.38	6399
2026-01-20	ANGO	10.34	0.15	1.91	2481
2026-01-21	ANGO	10.56	0.15	0.00	2488
2026-01-22	ANGO	10.61	0.15	0.00	2519
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ANGO	13.10	-150.0	-	-0.33
2025-12-29	ANGO	12.87	-150.0	-	-0.33
2025-12-30	ANGO	13.00	-150.0	-	-0.33
2025-12-31	ANGO	12.82	-150.0	-	-0.33
2026-01-02	ANGO	12.66	-150.0	-	-0.33
2026-01-05	ANGO	13.22	-150.0	-	-0.33
2026-01-06	ANGO	11.44	-150.0	-	-0.33
2026-01-07	ANGO	10.92	-150.0	-	-0.33
2026-01-08	ANGO	10.04	-150.0	-	-0.33
2026-01-09	ANGO	9.84	-466.7	-	-0.29
2026-01-12	ANGO	10.18	-466.7	-	-0.29
2026-01-13	ANGO	10.08	-466.7	-	-0.29
2026-01-14	ANGO	10.25	-466.7	-	-0.29
2026-01-15	ANGO	11.01	-466.7	-	-0.29
2026-01-16	ANGO	10.44	-466.7	-	-0.29
2026-01-20	ANGO	10.36	-466.7	-	-0.29
2026-01-21	ANGO	10.57	-466.7	-	-0.29
2026-01-22	ANGO	10.61	-466.7	-	-0.29
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ANGO	0.90	3.77	5.46
2025-12-29	ANGO	0.90	3.78	5.46
2025-12-30	ANGO	0.90	3.78	5.46
2025-12-31	ANGO	0.90	3.78	5.46
2026-01-02	ANGO	0.90	3.78	5.46
2026-01-05	ANGO	0.90	3.65	5.46
2026-01-06	ANGO	0.90	3.65	5.46
2026-01-07	ANGO	0.90	3.65	5.46
2026-01-08	ANGO	0.90	3.65	5.46
2026-01-09	ANGO	0.90	3.65	5.46
2026-01-12	ANGO	0.88	3.65	5.46
2026-01-13	ANGO	0.90	3.65	4.87
2026-01-14	ANGO	0.90	3.65	4.87
2026-01-15	ANGO	0.90	3.65	4.87
2026-01-16	ANGO	0.90	3.65	4.87
2026-01-20	ANGO	0.90	-0.13	4.87
2026-01-21	ANGO	0.90	-0.13	4.87
2026-01-22	ANGO	0.90	-0.13	5.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.11

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

0.9

Institutional Transactions

-0.13

Beta

0.53

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

66.8

Max Drawdown 5-Year %

-83

Target Price

19.33

P/E

Forward P/E

PEG

P/S

1.43

P/B

2.51

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y

-0.29

EPS Next Y. (Est.)

-0.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.02

Relative Volume

0.77

Return on Equity vs Sector %

-43

Return on Equity vs Industry %

-26.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

AngioDynamics, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 675

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

stock quote shares ANGO – Angiodynamic Inc Stock Price stock today

news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANGO – Angiodynamic Inc yahoo finance google finance

stock history ANGO – Angiodynamic Inc invest stock market

stock prices ANGO premarket after hours

ticker ANGO fair value insiders trading

BLCO – Bausch + Lomb Corporation

Float Short %

8.42

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.11

EPS Last/This Y

EPS This/Next Y

0.26

Price

17.19

Target Price

17.38

Analyst Recom

2.44

Performance Q

9.98

Relative Volume

0.73

Beta

0.61

Ticker: BLCO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	BLCO	17.18	0.16	0.06	2681
2025-12-29	BLCO	17.16	0.16	0.02	2748
2025-12-30	BLCO	17.18	0.16	0.00	2763
2025-12-31	BLCO	17.09	0.16	0.00	2817
2026-01-02	BLCO	16.56	0.15	1.29	2879
2026-01-05	BLCO	16.81	0.18	0.05	2907
2026-01-06	BLCO	17.12	0.19	0.00	2876
2026-01-07	BLCO	17.41	0.19	0.00	2888
2026-01-08	BLCO	17.32	0.18	0.00	2918
2026-01-09	BLCO	17.23	0.19	0.00	2848
2026-01-12	BLCO	17.51	0.19	0.50	2836
2026-01-13	BLCO	17.46	0.20	0.00	2839
2026-01-14	BLCO	17.31	0.18	0.00	3054
2026-01-15	BLCO	17.45	0.18	0.00	3095
2026-01-16	BLCO	17.15	0.18	0.00	3099
2026-01-20	BLCO	17.08	0.21	0.00	2683
2026-01-21	BLCO	17.26	0.20	0.06	2721
2026-01-22	BLCO	17.19	0.19	0.00	2882
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	BLCO	17.20	42.1	-	0.53
2025-12-29	BLCO	17.14	42.1	304.9	0.53
2025-12-30	BLCO	17.19	42.1	302.5	0.53
2025-12-31	BLCO	17.07	42.1	300.8	0.53
2026-01-02	BLCO	16.55	42.1	-	0.53
2026-01-05	BLCO	16.81	42.1	304.4	0.53
2026-01-06	BLCO	17.13	42.1	308.0	0.53
2026-01-07	BLCO	17.41	42.1	-	0.53
2026-01-08	BLCO	17.32	42.1	-	0.53
2026-01-09	BLCO	17.22	42.1	-	0.53
2026-01-12	BLCO	17.52	42.1	-	0.53
2026-01-13	BLCO	17.44	42.1	-	0.53
2026-01-14	BLCO	17.31	42.1	-	0.53
2026-01-15	BLCO	17.45	42.1	-	0.53
2026-01-16	BLCO	17.16	42.1	-	0.53
2026-01-20	BLCO	17.07	42.1	-	0.53
2026-01-21	BLCO	17.25	42.1	-	0.53
2026-01-22	BLCO	17.19	42.1	-	0.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	BLCO	0.00	-0.02	8.28
2025-12-29	BLCO	0.00	0.06	8.27
2025-12-30	BLCO	0.00	0.06	8.27
2025-12-31	BLCO	0.00	0.06	8.27
2026-01-02	BLCO	0.00	0.06	8.27
2026-01-05	BLCO	0.00	0.06	8.27
2026-01-06	BLCO	0.00	0.06	8.27
2026-01-07	BLCO	0.00	0.06	8.27
2026-01-08	BLCO	0.00	0.06	8.27
2026-01-09	BLCO	0.00	0.06	8.27
2026-01-12	BLCO	0.00	0.05	8.27
2026-01-13	BLCO	0.00	0.05	8.42
2026-01-14	BLCO	0.00	0.05	8.42
2026-01-15	BLCO	0.00	0.05	8.42
2026-01-16	BLCO	0.00	0.05	8.42
2026-01-20	BLCO	0.00	0.09	8.42
2026-01-21	BLCO	0.00	0.09	8.42
2026-01-22	BLCO	0.00	0.09	8.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.18

Avg. EPS Est. Current Quarter

0.36

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

Institutional Transactions

0.09

Beta

0.61

Average Sales Estimate Current Quarter

1383

Average Sales Estimate Next Quarter

1210

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.7

Max Drawdown 5-Year %

Target Price

17.38

P/E

Forward P/E

21.71

PEG

1.1

P/S

1.22

P/B

0.95

P/Free Cash Flow

EPS

-0.86

Average EPS Est. Cur. Y

0.53

EPS Next Y. (Est.)

0.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.13

Relative Volume

0.73

Return on Equity vs Sector %

-32

Return on Equity vs Industry %

-15.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Bausch + Lomb Corporation

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 13500

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today

news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance

stock history BLCO – Bausch + Lomb Corporation invest stock market

stock prices BLCO premarket after hours

ticker BLCO fair value insiders trading

No more stocks to show

UTMD – Utah Medical Products, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: UTMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

ATRI – Atrion Corp.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ATRI

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y